SEC Form 4 · accession 0001019687-15-001514
Ernexa Therapeutics Inc. · ERNA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ram Krishnan
Officer — CEO · Director
Period of report
Apr 15, 2015
Accepted (ET)
Apr 17, 2015 · 5:26 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000748592
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy)F1 | $0.41 | Apr 15, 2015 | A | 750,000 | A | Jan 1, 2016 | Apr 14, 2025 | Common Stock | 750,000 | 750,000 | D |
Explanation of responses
- F1Stock option granted under the NTN Buzztime, Inc. 2014 Inducement Plan. The stock option shall vest and become exercisable at the rate of 25% of the shares underlying the option on January 1, 2016 and the remaining 75% of the total number of shares of common stock shall become vested and exercisable in a series of 36 substantially equal monthly installments thereafter.